MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V)

T. Kawarai, R. Miyamoto, Y. Kuroda, M. Omoto, M. Ueyama, N. Murakami, T. Furukawa, R. Oki, A. Mori, Y. Osaki, C. Banzrai, H. Nodera, A. Orlacchio, A. Hashiguchi, Y. Higuchi, H. Takashima, T. Kanda, Y. Izumi, Y. Nagai, T. Mitsui, R. Kaji (Tokushima, Japan)

Meeting: 2016 International Congress

Abstract Number: 955

Keywords: Spasticity: Clinical features, Spasticity: Etiology and Pathogenesis, Spasticity: Genetics

Session Information

Date: Tuesday, June 21, 2016

Session Title: Spasticity

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To identify a genetic cause for hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V).

Background: Hereditary spastic paraplegia (HSP) constitutes a heterogeneous group of neurodegenerative disease characterized by the axonal degeneration of the longest descending (pyramidal) tracts. Clinically, HSP can overlap with other motor neuron diseases such as Charcot-Marie-Tooth (CMT) disease and ALS (amyotrophic lateral sclerosis). To date, genetic defect remains to be elucidated in approximately 20% case of HSP and 50% case of sporadic spastic paraplegia. Further identification of genetic defects in HSP would justify therapeutic strategies.

Methods: We performed a clinico-genetical study in a Japanese family, in which two sibships are affected with HMSN type V, including whole exome sequencing, bioinformatic analyses, pathological and ultrastructural study of biopsied nerve. Expression level of DNAJA3 was evaluated using quantitative PCR in Rat neuronal tissues. Biological effect of homozygous variant, p.Y95H in DNAJA3 gene, was evaluated by cell viability study in cultured cells. Suppression of endogenous Drosophila DNAJA3 using RNAi was also performed to evaluate its effects on motoneurons terminal synapsis and locomotive behaviour.

Results: Electrophysiological investigation revealed axonal degeneration in peripheral sensory and motor neurons. Electron microscopic examination demonstrated abnormal mitochondrial morphology in the biopsied sural nerve. Genetic analyses demonstrated a novel homozygous variant, p.Y95H, in DNAJA3 gene. The variant was not found in 618 control chromosomes recruited in Japan and Italy, and is predicted to be damaging/deleterious or disease causing. Higher level of DNAJA3 was also present in the nervous system, especially anterior horn, and lower level in hippocampus. Decreased viability in the cells expressing mutant DNAJA3 was demonstrated under the conditioning of rotenone-induced oxidative stress. Reduced expression of DNAJA3 showed reduced locomotor activity in Drosophila melanogaster.

Conclusions: A novel homozygous missense mutation, c.283T>C (p.Y95H), in DNAJA3 was identified in single family with hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V). The mutation would result in impairment of mitochondrial biogenesis leading to disruption of axonal maintenance.

To cite this abstract in AMA style:

T. Kawarai, R. Miyamoto, Y. Kuroda, M. Omoto, M. Ueyama, N. Murakami, T. Furukawa, R. Oki, A. Mori, Y. Osaki, C. Banzrai, H. Nodera, A. Orlacchio, A. Hashiguchi, Y. Higuchi, H. Takashima, T. Kanda, Y. Izumi, Y. Nagai, T. Mitsui, R. Kaji. A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V) [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/a-homozygous-loss-of-function-mutation-in-dnaja3-causes-hereditary-motor-and-sensory-neuropathy-with-spastic-paraplegia-hmsn-type-v/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-homozygous-loss-of-function-mutation-in-dnaja3-causes-hereditary-motor-and-sensory-neuropathy-with-spastic-paraplegia-hmsn-type-v/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley